Nuclear Medicine– our new study reveals trends, R&D progress, and predicted revenues
Where is the Nuclear Medicine market heading? If you are involved in this sector you must read this newly updated report. Visiongain’s report shows you the potential revenues streams to 2030, assessing data, trends, opportunities and business prospects there.
Discover how to stay ahead
Our 150+ page report provides 60 tables, 48 charts, and graphs. Read on to discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales at overall world market and regional level. See financial results, trends, opportunities, and revenue predictions. Much opportunity remains in this growing Nuclear Medicine Market. See how to exploit the opportunities.
Forecasts to 2030 and other analyses reveal the commercial prospects
– In addition to revenue forecasting to 2030, our new study provides you with recent results, growth rates, and market shares.
– You find original analyses, with business outlooks and developments.
– Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), product profiles and commercial developments.
Discover sales predictions for the world market and submarkets
Along with revenue prediction for the overall world market, there are 3 segmentations of the Nuclear Medicine market, with forecasts for 2 Types, 2 Applications each forecasted at a global and regional level.
Global Nuclear Medicine Market by Type
– Diagnostic Nuclear Medicine
– PET Radiopharmaceuticals
– F-18
– Ru-82
– Other PET Isotopes
– SPECT Radiopharmaceuticals
– Tc-99m
– Tl-201
– Ga-67
– I-123
– Other SPECT Isotopes
– Therapeutic Nuclear Medicine
– Alpha Emitters
– Ra-223
– Beta Emitters
– I-131
– Y-90
– Sm-153
– Re-186
– Lu-177
– Other Beta Emitters
– Brachytherapy Isotopes
– I-125
– Ir-192
– Pd-103
– Cs-131
– Other Brachytherapy Isotopes
Global Nuclear Medicine Market by Application
– Diagnostic Applications
– PET Applications
– Cardiology
– Oncology
– Neurology
– Other Pet Applications
– SPECT Applications
– Cardiology
– Lymphoma
– Neurology
– Thyroid
– Other SPECT Applications
– Therapeutic Applications
– Thyroid
– Bone Metastasis
– Endocrine Tumors
– Lymphoma
– Other Therapeutic Applications
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for 5 regional and 17 leading national markets:
– North America:
– U.S.
– Canada
– Latin America:
– Brazil
– Mexico
– Rest of Latin America
– Europe:
– Germany
– France
– UK
– Italy
– Spain
– Russia
– Rest of Europe
– Asia-Pacific:
– Japan
– China
– India
– Australia
– ASEAN
– Rest of Asia-Pacific
– MEA:
– GCC Countries
– South Africa
– Rest of MEA
The report also includes profiles and for some of the leading companies in the Nuclear Medicine market, with a focus on this segment of these companies’ operations.
There will be growth in both established and in developing countries. Our analyses show that the both developed and developing markets, U.S., Germany, UK and India, China in particular, will continue to achieve high revenue growth to 2030.
Leading companies and the potential for market growth
Overall world revenue for Nuclear Medicine Market will surpass $7 billion in 2020, our work calculates. We predict strong revenue growth through to 2030.
Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How the Nuclear Medicine Market report helps you
In summary, our 150+ page report provides you with the following knowledge:
– Revenue forecasts to 2030 for 3 segmentations of the Nuclear Medicine market, with forecasts for 2 Type,s 2 Applications, each forecasted at a global and regional level– discover the industry’s prospects, finding the most lucrative places for investments and revenues
– Revenue forecasts to 2030 for 5 regional and 17 key national markets – See forecasts for the Nuclear Medicine market in North America, Latin America, Europe, Asia-Pacific and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, Spain, Russia, China, India, Japan, Australia, ASEAN countries, GCC Countries and South Africa.
– Prospects for established firms and those seeking to enter the market– including company profiles for 16 major companies involved in the Nuclear Medicine market
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions.
Visiongain’s study is for everybody needing commercial analyses for the Nuclear Medicine market and leading companies. You will find data, trends and predictions.
Get our report today The Nuclear Medicine Market Forecast : Revenue Prospects by Type {Diagnostic Nuclear Medicine (PET Radiopharmaceuticals, SPECT Radiopharmaceuticals), Therapeutic Nuclear Medicine (Alpha Emitters, Beta Emitters, Brachytherapy Isotopes)}, Application {Diagnostic Applications (PET Applications, SPECT Applications), Therapeutic Applications (Bone Metastasis, Endocrine Tumors, Lymphoma, Thyroid, Other Therapeutic Applications)}, and Geography.
Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: sara.peerun@visiongain.com
1. Report Overview
1.1. Introduction
1.2. Why You Should Read This Report
1.3. Key Questions Answered by This Analytical Report
1.4. Who is This Report For?
1.5. Methodology
1.6. Frequently Asked Questions (FAQ)
1.7. Associated Visiongain Reports
1.8. About Visiongain
2. Nuclear Medicine Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Global Nuclear Medicine Market Size and Forecast
2.3. Market Dynamics
2.3.1. Market Drivers
2.3.1.1. Rising incidence of cancer and CVDs
2.3.1.2. Growing demand for the advance diagnostic methods
2.3.1.3. Growing applications of radiopharmaceuticals
2.3.1.4. Initiatives to lessen the demand-supply gap of Mo-99
2.3.2. Market Restraints/Challenges
2.3.2.1. Short half-life of radiopharmaceuticals
2.3.2.2. High equipment prices
2.3.2.3. High cost associated with diagnostic and therapeutic procedures
2.3.3. Opportunities
2.3.3.1. Use of radiopharmaceuticals in neurological applications
2.3.3.2. Growing patient pool in Asian countries
2.3.4. Global Nuclear Medicine Market: Trends
2.3.5. Mergers and Acquisitions
2.3.6. Entry of New Market Players
2.3.7. Regulatory Framework
3. Global Nuclear Medicine Market Analysis and Forecast, By Type
3.1. Introduction
3.1.1. Global Nuclear Medicine Market, Annual Growth Rate Comparison, By Type
3.2. Global Nuclear Medicine Market Size and Forecast, By Type
3.2.1. Diagnostic Nuclear Medicine
3.2.1.1. PET Radiopharmaceuticals
3.2.1.2. SPECT Radiopharmaceuticals
3.2.2. Therapeutic Nuclear Medicine
3.2.2.1. Alpha Emitters
3.2.2.2. Beta Emitters
3.2.2.3. Brachytherapy Isotopes
3.3. Global Nuclear Medicine Attractiveness Index, By Type
4. Global Nuclear Medicine Market Analysis and Forecast, By Application
4.1. Introduction
4.1.1. Global Nuclear Medicine Market, Annual Growth Rate Comparison, By Application
4.1.2. Global Nuclear Medicine Market Share Comparison, By Application (2018 & 2030)
4.2. Global Nuclear Medicine Market Size and Forecast, By Application
4.2.1. Diagnostic Applications
4.2.1.1. PET Applications
4.2.1.2. SPECT Applications
4.2.2. Therapeutic Applications
4.2.2.1. Thyroid
4.2.2.2. Bone Metastasis
4.2.2.3. Endocrine Tumors
4.2.2.4. Lymphoma
4.2.2.5. Other Therapeutic Applications
4.3. Global Nuclear Medicine Attractiveness Index, By Application
5. Global Nuclear Medicine Market Analysis and Forecast, By Region
5.1. Introduction
5.1.1. Global Nuclear Medicine Market, Annual Growth Rate Comparison, By Region
5.1.2. Global Nuclear Medicine Market Share Comparison, By Region (2018 & 2030)
5.2. Global Nuclear Medicine Market Size and Forecast, By Region
5.2.1. North America (U.S., Canada)
5.2.2. Latin America (Brazil, Mexico, Rest of Latin America)
5.2.3. Europe (UK, France, Germany, Italy, Spain, Russia, RoEU)
5.2.4. Asia Pacific (Japan, China, India, ASEAN, Australia, RoAPAC)
5.2.5. MEA (GCC, South Africa, RoMEA)
5.3. Global Nuclear Medicine Market Attractiveness Index, By Region
6. North America Nuclear Medicine Market Analysis and Forecast, 2020-2030
6.1. Introduction
6.1.1. North America Nuclear Medicine Market
6.1.2. North America Nuclear Medicine Market, Annual Growth Rate Comparison, By Country
6.2. North America Nuclear Medicine Market Size and Forecast, By Country
6.2.1. The U.S. Nuclear Medicine Market
6.2.2. Canada Nuclear Medicine Market
6.3. North America Nuclear Medicine Market Size and Forecast, By Type
6.4. North America Nuclear Medicine Market Size and Forecast, By Application
6.5. North America Nuclear Medicine Market Attractiveness Index, By Country
7. Latin America Nuclear Medicine Market Analysis and Forecast, 2020-2030
7.1. Introduction
7.1.1. Latin America Nuclear Medicine Market
7.1.2. Latin America Nuclear Medicine Market, Annual Growth Rate Comparison, By Country
7.2. Latin America Nuclear Medicine Market Size and Forecast, By Country
7.2.1. Brazil Nuclear Medicine Market
7.2.2. Mexico Nuclear Medicine Market
7.2.3. Rest of Latin America Nuclear Medicine Market
7.3. Latin America Nuclear Medicine Market Size and Forecast, By Type
7.4. Latin America Nuclear Medicine Market Size and Forecast, By Application
7.5. Latin America Nuclear Medicine Market Attractiveness Index, By Country
8. Europe Nuclear Medicine Market Analysis and Forecast, 2020-2030
8.1. Introduction
8.1.1. Europe Nuclear Medicine Market
8.1.2. Europe Nuclear Medicine Market, Annual Growth Rate Comparison, By Country
8.2. Europe Nuclear Medicine Market Size and Forecast, By Country
8.2.1. U.K. Nuclear Medicine Market
8.2.2. France Nuclear Medicine Market
8.2.3. Germany Nuclear Medicine Market
8.2.4. Italy Nuclear Medicine Market
8.2.5. Spain Nuclear Medicine Market
8.2.6. Russia Nuclear Medicine Market
8.2.7. Rest of Europe Nuclear Medicine Market
8.3. Europe Nuclear Medicine Market Size and Forecast, By Type
8.4. Europe Nuclear Medicine Market Size and Forecast, By Application
8.5. Europe Nuclear Medicine Market Attractiveness Index, By Country
9. Asia Pacific Nuclear Medicine Market Analysis and Forecast, 2020-2030
9.1. Introduction
9.1.1. Asia Pacific Nuclear Medicine Market
9.1.2. Asia Pacific Nuclear Medicine Market, Annual Growth Rate Comparison, By Country
9.2. Asia Pacific Nuclear Medicine Market Size and Forecast, By Country
9.2.1. China Nuclear Medicine Market
9.2.2. India Nuclear Medicine Market
9.2.3. Australia Nuclear Medicine Market
9.2.4. ASEAN Nuclear Medicine Market
9.2.5. Japan Nuclear Medicine Market
9.2.6. Rest of Asia Pacific Nuclear Medicine Market
9.3. Asia Pacific Nuclear Medicine Market Size and Forecast, By Type
9.4. Asia Pacific Nuclear Medicine Market Size and Forecast, By Application
9.5. Asia Pacific Nuclear Medicine Market Attractiveness Index, By Country
10. MEA Nuclear Medicine Market Analysis and Forecast, 2020-2030
10.1. Introduction
10.1.1. MEA Nuclear Medicine Market
10.1.2. MEA Nuclear Medicine Market, Annual Growth Rate Comparison, By Country
10.2. MEA Nuclear Medicine Market Size and Forecast, By Country
10.2.1. GCC Nuclear Medicine Market
10.2.2. South Africa Nuclear Medicine Market
10.2.3. Rest of MEA Nuclear Medicine Market
10.3. MEA Nuclear Medicine Market Size and Forecast, By Type
10.4. MEA Nuclear Medicine Market Size and Forecast, By Application
10.5. MEA Nuclear Medicine Market Attractiveness Index, By Country
11. Leading Companies in the Nuclear Medicine Market
11.1. Competition Dashboard
11.2. Company Share Analysis
11.3. Leading Players
11.4. Advanced Accelerator Applications (Aaa, Acquired By Novartis)
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance (2016-2018)
11.4.4. Recent Initiatives
11.5. Bayer
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance (2016-2018)
11.5.4. Recent Initiatives
11.6. Bracco Imaging S.P.A
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance (2016-2018)
11.6.4. Recent Initiatives
11.7. Cardinal Health
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance (2016-2018)
11.7.4. Recent Initiatives
11.8. Curium
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance (2016-2018)
11.8.4. Recent Initiatives
11.9. Eckert & Ziegler Group
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance (2016-2018)
11.9.4. Recent Initiatives
11.10. Eczacibasi-Monrol Nuclear Products
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance (2016-2018)
11.10.4. Recent Initiatives
11.11. GE Healthcare
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance (2016-2018)
11.11.4. Recent Initiatives
11.12. Jubilant Life Sciences Ltd.
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance (2016-2018)
11.12.4. Recent Initiatives
11.13. Lantheus Medical Imaging
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance (2016-2018)
11.13.4. Recent Initiatives
11.14. Mallinckrodt
11.14.1. Company Overview
11.14.2. Product Offerings
11.14.3. Financial Performance (2016-2018)
11.14.4. Recent Initiatives
11.15. Nordion (A Subsidiary of Sterigenics International)
11.15.1. Company Overview
11.15.2. Product Offerings
11.15.3. Financial Performance (2016-2018)
11.15.4. Recent Initiatives
11.16. NTP Radioisotopes SOC Ltd.
11.16.1. Company Overview
11.16.2. Product Offerings
11.16.3. Financial Performance (2016-2018)
11.16.4. Recent Initiatives
11.17. The Institute For Radioelements (IRE)
11.17.1. Company Overview
11.17.2. Product Offerings
11.17.3. Financial Performance (2016-2018)
11.17.4. Recent Initiatives
11.18. IBA Molecular Imaging
11.18.1. Company Overview
11.18.2. Product Offerings
11.18.3. Financial Performance (2016-2018)
11.18.4. Recent Initiatives
11.19. Ire-Elit SA
11.19.1. Company Overview
11.19.2. Product Offerings
11.19.3. Financial Performance (2016-2018)
11.19.4. Recent Initiatives
11.20. Fujifilm Holdings Corporation
11.20.1. Company Overview
11.20.2. Product Offerings
11.20.3. Financial Performance (2016-2018)
11.20.4. Recent Initiatives
11.21. Siemens AG
11.21.1. Company Overview
11.21.2. Product Offerings
11.21.3. Financial Performance (2016-2018)
11.21.4. Recent Initiatives
12. Conclusion
13. Glossary
LIST OF TABLES
Table 1 Global Nuclear Medicine Market Size, By Region, 2020-2030 (USD Mn, CAGR%)
Table 2 Global Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 3 Global Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 4 North America: Nuclear Medicine Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 5 North America: Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 6 North America: Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 7 U.S. Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 8 U.S. Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 9 Canada Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 10 Canada Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 11 Latin America: Nuclear Medicine Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 12 Latin America: Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 13 Latin America: Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 14 Brazil Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 15 Brazil Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 16 Mexico Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 17 Mexico Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 18 Rest of Latin America Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 19 Rest of Latin America Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 20 Europe: Nuclear Medicine Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 21 Europe: Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 22 Europe: Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 23 Germany Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 24 Germany Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 25 UK Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 26 UK Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 27 France Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 28 France Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 29 Italy Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 30 Italy Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 31 Spain Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 32 Spain Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 33 Russia Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 34 Russia Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 35 Rest of Europe Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 36 Rest of Europe Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 37 APAC: Nuclear Medicine Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 38 APAC: Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 39 APAC: Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 40 Japan Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 41 Japan Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 42 China Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 43 China Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 44 India Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 45 India Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 46 Australia Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 47 Australia Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 48 ASEAN Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 49 ASEAN Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 50 Rest of APAC Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 51 Rest of APAC Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 52 MEA: Nuclear Medicine Market Size, By Country, 2020-2030 (USD Mn, CAGR%)
Table 53 MEA: Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 54 MEA: Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 55 GCC Countries Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 56 GCC Countries Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 57 South Africa Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 58 South Africa Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
Table 59 Rest of MEA Nuclear Medicine Market Size, By Type, 2020-2030 (USD Mn, CAGR%)
Table 60 Rest of MEA Nuclear Medicine Market Size, By Application, 2020-2030 (USD Mn, CAGR%)
LIST OF FIGURES
Figure 1 Nuclear Medicine Market Segmentation
Figure 2 Drivers, Restraints, Opportunities, and Challenges in the Nuclear Medicine Market
Figure 3 Value Chain Analysis
Figure 4 Porter’s Five Forces Analysis
Figure 5 Global Nuclear Medicine Market, By Type (2020-2030)
Figure 6 Global Nuclear Medicine Market, By Application (2020-2030)
Figure 7 Global Nuclear Medicine Market, By Region
Figure 8 North America Nuclear Medicine Market Snapshot
Figure 9 U.S. Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 10 Canada Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 11 Europe Nuclear Medicine Market Snapshot
Figure 12 Germany Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 13 France Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 14 UK Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 15 Italy Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 16 Spain Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 17 Russia Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 18 APAC Nuclear Medicine Market Snapshot
Figure 19 Japan Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 20 China Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 21 India Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 22 Australia Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 23 ASEAN Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 24 Latin America Nuclear Medicine Market Snapshot
Figure 25 Brazil Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 26 Mexico Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 27 MEA Nuclear Medicine Market Snapshot
Figure 28 GCC Countries Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 29 South Africa Nuclear Medicine Market, 2020-2030 (USD Mn)
Figure 30 Company Market Share Analysis
Figure 31 Advanced Accelerator Applications (Aaa, Acquired By Novartis) Financial Snapshot
Figure 32 Bayer Financial Snapshot
Figure 33 Bracco Imaging S.P.A Financial Snapshot
Figure 34 Cardinal Health Financial Snapshot
Figure 35 Curium Financial Snapshot
Figure 36 Eckert & Ziegler Group Financial Snapshot
Figure 37 Eczacibasi-Monrol Nuclear Products Financial Snapshot
Figure 38 GE Healthcare Financial Snapshot
Figure 39 Jubilant Life Sciences Ltd. Financial Snapshot
Figure 40 Lantheus Medical Imaging Financial Snapshot
Figure 41 Mallinckrodt Financial Snapshot
Figure 42 Nordion (A Subsidiary of Sterigenics International) Financial Snapshot
Figure 43 NTP Radioisotopes SOC Ltd. Financial Snapshot
Figure 44 The Institute For Radioelements (IRE) Financial Snapshot
Figure 45 IBA Molecular Imaging Financial Snapshot
Figure 46 Ire-Elit SA Financial Snapshot
Figure 47 Fujifilm Holdings Corporation Financial Snapshot
Figure 48 Siemens AG Financial Snapshot